ArticleJournal of experimental & clinical cancer research : CR2019

The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.

Ina Patties et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.